Src is implicated in prostate cancer progression and metastasis, therefore treatment with Src inhibitors warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Joanne Edwards (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: